Latest news with #CHF1.93

Business Insider

Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

Barclays analyst Yihan Li maintained a Buy rating on Galderma Group AG on July 25 and set a price target of CHF140.00. The company's shares closed last Friday at CHF134.50. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Li is ranked #6568 out of 9862 analysts. Galderma Group AG has an analyst consensus of Strong Buy, with a price target consensus of CHF130.52, which is a -2.96% downside from current levels. In a report released on July 25, Citi also maintained a Buy rating on the stock with a CHF140.00 price target. Based on Galderma Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF1.93 billion and a net profit of CHF160.43 million. In comparison, last year the company earned a revenue of CHF1.84 billion and had a GAAP net loss of CHF54.18 million